Chronic Kidney Disease
1,053
78
102
664
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
221 trials with published results (21%)
Research Maturity
664 completed trials (63% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.1%
75 terminated out of 1053 trials
89.9%
+3.3% vs benchmark
24%
257 trials in Phase 3/4
33%
221 of 664 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 664 completed trials
Clinical Trials (1053)
Cancer and Blood Pressure Management, CARISMA Study
Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.
Mechanisms of Diabetic Nephropathy in Ecuador
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease
A Natural History Study of Metabolic Sizing in Health and Disease
A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit
A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease
An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk Score
The Mindful Kidney: Supporting Mindfulness for Adults With Chronic Kidney Disease
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
OPTIMISE-CKD Study_Dapagliflozin Effectiveness in CKD
Pleural Effusion Types in Chronic Kidney Disease
Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome
Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia
Empagliflozin Treatment in Kidney Transplant Recipients
Vibration Massage, Static Stretching Exercise, Intradialytic Muscle Cramps and Stress